Array Comparative Genomic Hybridization (CGH) has been shown as an effective method to identify BRCA1-mutated breast cancers and sporadic cases with a BRCA1-like profile [46],[47] for appropriate chemotherapeutics, and to distinguish BRCA2-mutated tumors from sporadic breast tumors [48]. Here, BRCA2 is linked to breast carcinoma.